NEWAMSTERDAM PHARMA COMPANY NAMS
September 12, 2024 - 8:09am EST by
member
| 2024 | 2025 | ||||||
| Price: | 16.16 | EPS | 0 | 0 | |||
| Shares Out. (in M): | 113 | P/E | 0 | 0 | |||
| Market Cap (in $M): | 1,818 | P/FCF | 0 | 0 | |||
| Net Debt (in $M): | 431 | EBIT | 0 | 0 | |||
| TEV (in $M): | 1,387 | TEV/EBIT | 0 | 0 | |||
